
Renalytix Investor Relations Material
Latest events

Q3 2024
Renalytix
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Renalytix Plc
Access all reports
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company's lead product candidate is KidneyIntelX, a non-invasive blood test to predict the risk of rapid decline in kidney function, progression to kidney failure, and comorbidities related to Chronic Kidney Disease (CKD), including acute kidney injury, cardiovascular disease, and anemia.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
RENX
Country
🇬🇧 United Kingdom